We reassess every 6 weeks (or every 510 pounds of weight loss) to see whats shifted and what needs support
Latifian S, Hamdi K, Totakneh R
These thresholds were chosen to ensure consistency in patient selection and comparability with previous reports
This approval was significant because it marked the first time since 2014 that the FDA had approved a new drug for this purpose
Semaglutide is also FDA-approved to treat metabolic dysfunction-associated steatohepatitis (MASH), a condition that causes inflammation and scarring in the liver, including more serious scarring called advanced fibrosis
In other words, your insurance plan may be more likely to cover Wegovy or Saxenda for chronic weight management , as opposed to Ozempic or Mounjaro, which are approved for type 2 diabetes